>Recent national attention to the problem of concussion and sports presents an opportunity to promote safety an...
The first drug approved specifically to manage a symptom of MS is shown to improve patients’ walking ability...
>A look at FTD’s symptoms, pathophysiology, subtypes, as well as the latest from imaging studies.
The pSS literature has reported varying degrees of central nervous system involvement in individuals with this...
Studies suggest that the presence of cognitive fluctuations and abnormalities in episodic memory and delayed r...
Clinicians must exercise caution when providing “unofficial” advice for individuals not under their care.
Care of a patient with AIS is comprehensive and requires a team approach. Clinicians must be able to control a...
News // DBS Safe in Alzheimer’s
A phase I safety trial of six Canadian patients using deep brain stimulation to treat early signs of Alzheimer disease, found the intervention is safe and may help improve memory, The research took pl...
A look at FTD’s symptoms, pathophysiology, subtypes, as well as the latest from imaging studies. more >
Recent national attention to the problem of concussion and sports presents an opportunity to promote safety and establish guidelines for improved diagnosis and management. more >
New oral agents—approved and in the pipeline—may instigate an evolution in the treatment of MS. more >
Practical Neurology strives to enhance quality of care and improve the daily operation of neurology practices. Each month, our experts explain the real-world significance of recent advances in neurologic science and offer step-by-step advice on how to overcome the clinical and business challenges neurologists face. Our straightforward, how-to articles give neurologists tools they can put into practice right away.